Abstract: . . .  comparison with previous trials. Drugs & Aging. 1994;5:171-183. 20. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR.. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:18811884. 21. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: The roles of age, gender, and race. Am J Public Health. 1996;85: 18051808. 22. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:24132446. 23. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 19881991. Hypertension . 1995;25:305313. References P0001123I 2000, Pfizer Inc Printed in USA/February 2000 p U.S. Pharmaceuticals  . . .
--1875,1,938,1209,9374